We all hope so! If we get another 'Complete Response Letter' SI will have a lot of explaining to do!
The plan was Adult Trial and now all of a sudden that's out the window? The recent capital raise was to fund adult trial???
Use of Proceeds
Proceeds from the Placement and Entitlement Offer and existing cash reserves will be used to fund the
adult Phase 3 registration trials for steroid-refractory acute-graft versus host disease and for chronic
lower back pain, and general corporate purposes
Someone changed goal posts again! Is it the FDA or is SI playing with us. This is what annoys investors! I must agree with Pledge's sentiments.
I'll be nervous leading to the second half of 2024! This will be pivotal time for MSB.
- Forums
- ASX - By Stock
- MSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-78
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B |
Open | High | Low | Value | Volume |
$1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 29782 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 55197 | 1.525 |
2 | 7393 | 1.520 |
5 | 63970 | 1.515 |
7 | 88983 | 1.510 |
4 | 60982 | 1.505 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 29782 | 3 |
1.540 | 111981 | 9 |
1.545 | 118548 | 7 |
1.550 | 105230 | 23 |
1.555 | 640 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online